Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.06 BRL | -8.44% | -2.21% | -13.75% |
May. 08 | Transcript : Wilson Sons S.A., Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | EARNINGS: International Biotechnology bullish; Andrews Sykes profit up | AN |
Sales 2024 * | 469M 2.51B | Sales 2025 * | 544M 2.91B | Capitalization | 1.26B 6.73B |
---|---|---|---|---|---|
Net income 2024 * | 69M 369M | Net income 2025 * | 77M 412M | EV / Sales 2024 * | 3.72 x |
Net Debt 2024 * | 484M 2.59B | Net Debt 2025 * | 464M 2.48B | EV / Sales 2025 * | 3.16 x |
P/E ratio 2024 * |
18.2
x | P/E ratio 2025 * |
16.2
x | Employees | 3,800 |
Yield 2024 * |
2.76% | Yield 2025 * |
3.11% | Free-Float | 43.48% |
Latest transcript on Wilson Sons S.A.
1 day | -8.44% | ||
1 week | -2.21% | ||
Current month | -2.21% | ||
1 month | -8.23% | ||
3 months | -15.87% | ||
6 months | -3.77% | ||
Current year | -13.75% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 15-12-31 | |
Chairman | 64 | 93-12-31 | |
Chief Operating Officer | 67 | 79-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
William Salomon
BRD | Director/Board Member | 66 | - |
Chairman | 64 | 93-12-31 | |
Director/Board Member | 74 | 90-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 32 M€ | +4.30% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 15.06 | -1.70% | 366,600 |
24-06-06 | 15.32 | +1.06% | 278,200 |
24-06-05 | 15.16 | -0.66% | 378,200 |
24-06-04 | 15.26 | -0.07% | 348,100 |
24-06-03 | 15.27 | -0.84% | 475,700 |
Delayed Quote Sao Paulo, June 07, 2024 at 04:06 pm EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.75% | 1.26B | |
+43.60% | 12.27B | |
+21.24% | 6.41B | |
+3.86% | 2.42B | |
-11.61% | 2.06B | |
+8.03% | 1.77B | |
+18.30% | 1.02B | |
-.--% | 1.01B | |
+9.05% | 684M | |
+25.87% | 643M |
- Stock Market
- Equities
- PORT3 Stock